Market

Annual Results

You can view the Annual Results for the last 5 years.

ANNUAL RESULTS

Suven Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 16437.26 P/BV 9.47 Book Value ( ₹ ) 68.16
52 Week High/Low ( ₹ ) 768/469 FV/ML 1/1 P/E(X) 39.97
Book Closure 15/12/2023 EPS ( ₹ ) 16.16 Div Yield (%) 0.00
(₹ in Crs.)

ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
Net Sales/Income from operations1340.331320.221009.72833.79377.83
Total Income From Operations1340.331320.221009.72833.79377.83
      
EXPENDITURE     
Consumption of Raw Materials430.08459.46310.32240.24124.52
Increase/Decrease in Stocks-20.94-60.35-8.37-11.05-21.32
Employees Cost110.51100.4876.2373.7229.63
Depreciation47.7339.1031.6423.8611.50
ResearchAndDevlopmentExpenses8.5910.3511.060.000.00
Other Expenses245.56230.85180.01145.7773.45
Total Expenses821.53779.89600.87472.54217.78
      
P/L Before Other Inc. , Int., Excpt. Items & Tax518.80540.33408.84361.25160.06
Other Income46.3692.3814.2418.120.60
P/L Before Interest, Excpt. Items & Tax565.17632.71423.08379.37160.66
Interest5.446.239.1423.072.79
P/L Before Exceptional Items & Tax559.73626.48413.94356.30157.87
P/L Before Tax559.73626.48413.94356.30157.87
Tax148.44213.78105.3387.5148.59
P/L After Tax from Ordinary Activities411.29412.69308.61268.79109.27
Net Profit/Loss For the Period411.29412.69308.61268.79109.27
Share Of P/L Of Associates0.0041.1153.7448.210.00
Net P/L After Minority Interest & Share Of Associates411.29453.80362.34317.00109.27
      
Equity Share Capital25.4625.4625.4612.7312.73
Reserves And Surplus1709.731501.721155.35832.03577.56
EPS Before Extra Ordinary *     
Basic EPS (Rs.)16.1617.8314.2324.918.59
Diluted EPS (Rs.)16.1617.8314.2324.918.59
EPS After Extra Ordinary *     
Basic EPS (Rs.) 16.1617.8314.2324.918.59
Diluted EPS (Rs.) 16.1617.8314.2324.918.59
      
PBITOE Margin (%)38.7040.9240.4943.3242.36
PBTE Margin (%)41.7647.4540.9942.7341.78
PBT Margin (%)41.7647.4540.9942.7341.78
PAT Margin (%)30.6834.3735.8838.0128.92
PAT After MI And SOA Margin (%)30.6834.3735.8838.0128.92
ParticularsMar 23
Net Sales/Income from operations1340.33
Total Income From Operations1340.33
  
EXPENDITURE 
Consumption of Raw Materials430.08
Increase/Decrease in Stocks-20.94
Employees Cost110.51
Depreciation47.73
ResearchAndDevlopmentExpenses8.59
Other Expenses245.56
Total Expenses821.53
P/L Before Other Inc. , Int., Excpt. Items & Tax518.80
Other Income46.36
P/L Before Interest, Excpt. Items & Tax565.17
Interest5.44
P/L Before Exceptional Items & Tax559.73
P/L Before Tax559.73
Tax148.44
P/L After Tax from Ordinary Activities411.29
Net Profit/Loss For the Period411.29
Share Of P/L Of Associates0.00
Net P/L After Minority Interest & Share Of Associates411.29
Equity Share Capital25.46
Reserves And Surplus1709.73
EPS Before Extra Ordinary * 
Basic EPS (Rs.)16.16
Diluted EPS (Rs.)16.16
EPS After Extra Ordinary * 
Basic EPS (Rs.) 16.16
Diluted EPS (Rs.) 16.16
PBITOE Margin (%)38.70
PBTE Margin (%)41.76
PBT Margin (%)41.76
PAT Margin (%)30.68
PAT After MI And SOA Margin (%)30.68